NCT03003988

Brief Summary

This study was designed to examine how different forms of creatine impact active males.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2014

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

December 14, 2016

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 28, 2016

Completed
Last Updated

January 4, 2017

Status Verified

January 1, 2017

Enrollment Period

3 months

First QC Date

December 14, 2016

Last Update Submit

January 2, 2017

Conditions

Outcome Measures

Primary Outcomes (8)

  • Effects of 28 Days of Different Forms of Creatine Supplementation on Body Water

    Assessing Body Water through Bioelectrical Impedance Analysis (BIA)

    28 Days

  • Effects of 28 Days of Different Forms of Creatine Supplementation on Body Composition

    Assessing Body Compositing through Dual-Energy X-Ray Absorptiometry (DXA)

    28 Days

  • Effects of 28 Days of Different Forms of Creatine Supplementation on intramuscular creatine

    Assessing intramuscular creatine using standard spectrophotometric methods using a microplate spectrophotometer

    28 Days

  • Effects of 28 Days of Different Forms of Creatine Supplementation on intramuscular phosphocreatine

    Assessing intramuscular phosphocreatine using standard spectrophotometric methods using a microplate spectrophotometer

    28 Days

  • Effects of 28 Days of Different Forms of Creatine Supplementation on intramuscular ATP

    Assessing intramuscular Adenosine Triphosphate (ATP) using standard spectrophotometric methods using a microplate spectrophotometer

    28 Days

  • Effects of 28 Days of Different Forms of Creatine Supplementation on muscular strength

    Assessing muscular strength through 1 Repetition Maximum (RM) testing

    28 Days

  • Effects of 28 Days of Different Forms of Creatine Supplementation on muscular endurance

    Assessing muscular endurance through repetition to failure testing

    28 Days

  • Effects of 28 Days of Different Forms of Creatine Supplementation on anaerobic capacity

    Assessing anaerobic capacity through 6 x 6 second sprints followed by a 30 second sprint on a Wingate bicycle ergometer

    28 Days

Secondary Outcomes (3)

  • Effects of 28 Days of Different Forms of Creatine Supplementation on training volume (weight lifted x number of repetitions x number of sets)

    28 Days

  • Effects of 28 Days of Different Forms of Creatine Supplementation on self-reported side effects

    28 Days

  • Effects of 28 Days of Different Forms of Creatine Supplementation on blood

    28 Days

Study Arms (3)

Creatine monohydrate

EXPERIMENTAL

Creatine monohydrate (6.0 g.) + dextrose (0.5 g.)

Dietary Supplement: Creatine monohydrate

Creatine nitrate

ACTIVE COMPARATOR

Creatine nitrate (5.0 g. creatine monohydrate + 1.5 g. creatine nitrate that provides 1.0 g. of creatine and 0.5 g. nitrate in 2:1 ratio).

Dietary Supplement: Creatine nitrate

Placebo

PLACEBO COMPARATOR

6.5 g. dextrose

Dietary Supplement: Placebo

Interventions

Creatine monohydrateDIETARY_SUPPLEMENT

Creatine monohydrate (6.0 g) + dextrose (0.5 g)

Creatine monohydrate
Creatine nitrateDIETARY_SUPPLEMENT

Creatine nitrate (5.0 g creatine monohydrate + 1.5 g. creatine nitrate that provides 1.0 g. of creatine and 0.5 g. nitrate in 2:1 ratio)

Creatine nitrate
PlaceboDIETARY_SUPPLEMENT

Placebo (6.5 g dextrose)

Placebo

Eligibility Criteria

Age18 Years - 40 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • participants are apparently healthy and recreationally active males between the ages of 18 and 40;
  • participants will need to have at least six months immediate prior history of resistance training on the bench press and leg press or squat;

You may not qualify if:

  • participants have a history of treatment for metabolic disease (i.e., diabetes), hypertension, hypotension, thyroid disease, arrhythmias and/or cardiovascular disease;
  • participants are currently using prescription medications;
  • participants have a history of smoking;
  • participants drink excessively (i.e., 12 drinks per week or more);
  • participants have a recent history of creatine supplementation within six weeks of the start of supplementation;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Creatine

Intervention Hierarchy (Ancestors)

GuanidinesAmidinesOrganic ChemicalsAmino AcidsAmino Acids, Peptides, and Proteins

Study Officials

  • Richard B Kreider, PhD

    Texas A&M University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 14, 2016

First Posted

December 28, 2016

Study Start

September 1, 2014

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

January 4, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will not share